Biotech

Latest Articles

Former Seagen CEO reveals new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2015 for a tremendous $43 b...

Ironwood creates additional bid for $1B GI drug along with brand new subgroup data

.On the heels of a phase 3 succeed that fell short to wow real estate investors, Ironwood Pharmaceut...

Novartis inks $150M package for autoimmune molecular adhesive

.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizin...

Jade takes exec crew along with Chinook veterinarians-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant management hirings, shootings as ...

Septerna goes public with upsized offering of $288M

.Commemorating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer calle...

AbbVie makes Richter wealthier, paying out $25M to form breakthrough deal

.AbbVie has come back to the source of its antipsychotic giant Vraylar looking for one more smash hi...

GenSight goes into ultimate weeks of cash runway as earnings flow slips by of scope

.GenSight Biologics is weeks away from running out of cash. Once again. The biotech only has enough ...

AZ licenses disposed of rare illness medication to Monopar Therapeutics

.Monopar Therapies is actually bouncing back a medication coming from the dump of AstraZeneca's rare...

Arcus' brand-new HIF-2a information in kidney cancer cells hint at prospective edge over Merck's Welireg, experts claim

.Along with brand new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one group...

Roche wagers as much as $1B to extend Dyno genetics treatment delivery contract

.After developing a gene therapy collaboration with Dyno Therapeutics in 2020, Roche is back for eve...

Lundbeck slashes market value of $250M Abide purchase after pain misfortune

.Lundbeck is actually lowering the book value of its own $250 million Abide Therapeutics acquistion ...

Real- World Information Meets Scientific Trial Concept: Optimizing Procedures and Site Variety

.The combination of real-world data (RWD) in to process usefulness and also website option has becom...

Where are they presently? Overtaking past Fierce 15 guest of honors

.At this year's Intense Biotech Summit in Boston, our company caught up with leaders in the biotech ...

Merck purchases preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually putting down $30 thousand upfront to buy Yale spinout Modifi Biosciences...

Radiopharma Alpha-9 raises $175M set C to money medical push

.Alpha-9 Oncology has actually elevated a $175 thousand set C round to bankroll its own clinical-sta...

Ocuphire to transform right into genetics treatment biotech using Piece purchase

.Eye medicine manufacturer Ocuphire Pharma is actually obtaining genetics therapy creator Opus Genes...

Roche culls cough applicant, rotates KRAS plan in Q3 upgrade

.Roche's chronic cough course has actually faltered to a standstill. The drugmaker, which axed the s...

Merck- Gilead long-acting dental combo restrains HIV for 48 weeks

.Gilead Sciences and also Merck &amp Co. have actually directed their once-weekly HIV combo treatmen...

Lykos allows FDA check out that MDMA permission depends on fresh trial

.Lykos Therapeutics may possess lost three-quarters of its own team back the FDA's rejection of its ...

Septerna organizes $158M IPO to cash readouts for GPCR pipe

.Septerna might be as yet to reveal "any type of significant professional information," however the ...